SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-17-073617
Filing Date
2017-12-15
Accepted
2017-12-15 16:05:37
Documents
10
Period of Report
2017-10-02
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a17-28481_18ka.htm 8-K/A 32341
2 EX-23.1 a17-28481_1ex23d1.htm EX-23.1 4763
3 EX-23.2 a17-28481_1ex23d2.htm EX-23.2 4770
4 EX-99.1 a17-28481_1ex99d1.htm EX-99.1 628252
5 EX-99.2 a17-28481_1ex99d2.htm EX-99.2 682493
6 EX-99.3 a17-28481_1ex99d3.htm EX-99.3 552925
7 EX-99.4 a17-28481_1ex99d4.htm EX-99.4 296412
8 GRAPHIC g284811mq01i001.jpg GRAPHIC 9829
9 GRAPHIC g284811mm01i001.jpg GRAPHIC 7358
10 GRAPHIC g284811mo01i001.jpg GRAPHIC 7149
  Complete submission text file 0001104659-17-073617.txt   2237020
Mailing Address 2800 Patton Rd St Paul MN 55113
Business Address 2800 Patton Rd St Paul MN 55113 651-634-3003
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33818 | Film No.: 171259031
SIC: 3845 Electromedical & Electrotherapeutic Apparatus